nodes	percent_of_prediction	percent_of_DWPC	metapath
Famotidine—HRH2—gastric juice—stomach cancer	0.146	0.58	CbGeAlD
Famotidine—HRH2—hematopoietic system—stomach cancer	0.0128	0.0509	CbGeAlD
Famotidine—SLC47A1—hematopoietic system—stomach cancer	0.00989	0.0393	CbGeAlD
Famotidine—HRH2—digestive system—stomach cancer	0.00891	0.0354	CbGeAlD
Famotidine—SLC22A2—digestive system—stomach cancer	0.00813	0.0323	CbGeAlD
Famotidine—SLC22A8—hematopoietic system—stomach cancer	0.00759	0.0301	CbGeAlD
Famotidine—HRH2—endocrine gland—stomach cancer	0.00736	0.0292	CbGeAlD
Famotidine—SLC47A1—digestive system—stomach cancer	0.00688	0.0273	CbGeAlD
Famotidine—HRH2—liver—stomach cancer	0.00664	0.0264	CbGeAlD
Famotidine—CYP2C19—hematopoietic system—stomach cancer	0.00636	0.0253	CbGeAlD
Famotidine—SLC47A1—endocrine gland—stomach cancer	0.00568	0.0226	CbGeAlD
Famotidine—SLC47A1—liver—stomach cancer	0.00513	0.0203	CbGeAlD
Famotidine—HRH2—lymph node—stomach cancer	0.00509	0.0202	CbGeAlD
Famotidine—CYP2C19—digestive system—stomach cancer	0.00442	0.0176	CbGeAlD
Famotidine—SLC47A1—lymph node—stomach cancer	0.00393	0.0156	CbGeAlD
Famotidine—CYP2C19—endocrine gland—stomach cancer	0.00366	0.0145	CbGeAlD
Famotidine—CYP2C19—liver—stomach cancer	0.0033	0.0131	CbGeAlD
Famotidine—Jaundice—Epirubicin—stomach cancer	0.000837	0.00128	CcSEcCtD
Famotidine—Neutropenia—Doxorubicin—stomach cancer	0.000833	0.00127	CcSEcCtD
Famotidine—Dysuria—Doxorubicin—stomach cancer	0.000833	0.00127	CcSEcCtD
Famotidine—Hypersensitivity—Fluorouracil—stomach cancer	0.000829	0.00127	CcSEcCtD
Famotidine—Dry mouth—Docetaxel—stomach cancer	0.000828	0.00127	CcSEcCtD
Famotidine—Upper respiratory tract infection—Doxorubicin—stomach cancer	0.000828	0.00127	CcSEcCtD
Famotidine—Hepatitis—Methotrexate—stomach cancer	0.000824	0.00126	CcSEcCtD
Famotidine—Pollakiuria—Doxorubicin—stomach cancer	0.000823	0.00126	CcSEcCtD
Famotidine—Chest pain—Capecitabine—stomach cancer	0.00082	0.00125	CcSEcCtD
Famotidine—Arthralgia—Capecitabine—stomach cancer	0.00082	0.00125	CcSEcCtD
Famotidine—Myalgia—Capecitabine—stomach cancer	0.00082	0.00125	CcSEcCtD
Famotidine—Haematuria—Epirubicin—stomach cancer	0.000819	0.00125	CcSEcCtD
Famotidine—Confusional state—Docetaxel—stomach cancer	0.000819	0.00125	CcSEcCtD
Famotidine—Pharyngitis—Methotrexate—stomach cancer	0.000817	0.00125	CcSEcCtD
Famotidine—Anxiety—Capecitabine—stomach cancer	0.000817	0.00125	CcSEcCtD
Famotidine—Photosensitivity reaction—Doxorubicin—stomach cancer	0.000813	0.00124	CcSEcCtD
Famotidine—Oedema—Docetaxel—stomach cancer	0.000812	0.00124	CcSEcCtD
Famotidine—Anaphylactic shock—Docetaxel—stomach cancer	0.000812	0.00124	CcSEcCtD
Famotidine—Infection—Docetaxel—stomach cancer	0.000807	0.00123	CcSEcCtD
Famotidine—Sinusitis—Epirubicin—stomach cancer	0.000806	0.00123	CcSEcCtD
Famotidine—Diarrhoea—Irinotecan—stomach cancer	0.000804	0.00123	CcSEcCtD
Famotidine—Dry mouth—Capecitabine—stomach cancer	0.000802	0.00123	CcSEcCtD
Famotidine—Agranulocytosis—Epirubicin—stomach cancer	0.000801	0.00122	CcSEcCtD
Famotidine—Shock—Docetaxel—stomach cancer	0.000799	0.00122	CcSEcCtD
Famotidine—Pruritus—Fluorouracil—stomach cancer	0.000796	0.00122	CcSEcCtD
Famotidine—Thrombocytopenia—Docetaxel—stomach cancer	0.000795	0.00121	CcSEcCtD
Famotidine—Confusional state—Capecitabine—stomach cancer	0.000793	0.00121	CcSEcCtD
Famotidine—Stevens-Johnson syndrome—Doxorubicin—stomach cancer	0.000788	0.0012	CcSEcCtD
Famotidine—Oedema—Capecitabine—stomach cancer	0.000786	0.0012	CcSEcCtD
Famotidine—Bradycardia—Epirubicin—stomach cancer	0.000785	0.0012	CcSEcCtD
Famotidine—Infection—Capecitabine—stomach cancer	0.000781	0.00119	CcSEcCtD
Famotidine—Erythema multiforme—Methotrexate—stomach cancer	0.000779	0.00119	CcSEcCtD
Famotidine—Dizziness—Irinotecan—stomach cancer	0.000777	0.00119	CcSEcCtD
Famotidine—Jaundice—Doxorubicin—stomach cancer	0.000774	0.00118	CcSEcCtD
Famotidine—Anorexia—Docetaxel—stomach cancer	0.000774	0.00118	CcSEcCtD
Famotidine—Shock—Capecitabine—stomach cancer	0.000773	0.00118	CcSEcCtD
Famotidine—Hepatitis—Epirubicin—stomach cancer	0.000771	0.00118	CcSEcCtD
Famotidine—Diarrhoea—Fluorouracil—stomach cancer	0.00077	0.00118	CcSEcCtD
Famotidine—Thrombocytopenia—Capecitabine—stomach cancer	0.00077	0.00118	CcSEcCtD
Famotidine—Tinnitus—Methotrexate—stomach cancer	0.000768	0.00117	CcSEcCtD
Famotidine—Pharyngitis—Epirubicin—stomach cancer	0.000765	0.00117	CcSEcCtD
Famotidine—Haematuria—Doxorubicin—stomach cancer	0.000757	0.00116	CcSEcCtD
Famotidine—Anorexia—Capecitabine—stomach cancer	0.000749	0.00114	CcSEcCtD
Famotidine—Vomiting—Irinotecan—stomach cancer	0.000747	0.00114	CcSEcCtD
Famotidine—Sinusitis—Doxorubicin—stomach cancer	0.000745	0.00114	CcSEcCtD
Famotidine—Dizziness—Fluorouracil—stomach cancer	0.000744	0.00114	CcSEcCtD
Famotidine—Agranulocytosis—Doxorubicin—stomach cancer	0.000741	0.00113	CcSEcCtD
Famotidine—Rash—Irinotecan—stomach cancer	0.000741	0.00113	CcSEcCtD
Famotidine—Dermatitis—Irinotecan—stomach cancer	0.00074	0.00113	CcSEcCtD
Famotidine—Musculoskeletal discomfort—Docetaxel—stomach cancer	0.00074	0.00113	CcSEcCtD
Famotidine—Headache—Irinotecan—stomach cancer	0.000736	0.00112	CcSEcCtD
Famotidine—Insomnia—Docetaxel—stomach cancer	0.000734	0.00112	CcSEcCtD
Famotidine—Paraesthesia—Docetaxel—stomach cancer	0.000729	0.00111	CcSEcCtD
Famotidine—Erythema multiforme—Epirubicin—stomach cancer	0.000729	0.00111	CcSEcCtD
Famotidine—Alopecia—Methotrexate—stomach cancer	0.000728	0.00111	CcSEcCtD
Famotidine—Bradycardia—Doxorubicin—stomach cancer	0.000726	0.00111	CcSEcCtD
Famotidine—Somnolence—Docetaxel—stomach cancer	0.000722	0.0011	CcSEcCtD
Famotidine—Mental disorder—Methotrexate—stomach cancer	0.000722	0.0011	CcSEcCtD
Famotidine—Tinnitus—Epirubicin—stomach cancer	0.000719	0.0011	CcSEcCtD
Famotidine—Musculoskeletal discomfort—Capecitabine—stomach cancer	0.000716	0.00109	CcSEcCtD
Famotidine—Flushing—Epirubicin—stomach cancer	0.000715	0.00109	CcSEcCtD
Famotidine—Vomiting—Fluorouracil—stomach cancer	0.000715	0.00109	CcSEcCtD
Famotidine—Dyspepsia—Docetaxel—stomach cancer	0.000715	0.00109	CcSEcCtD
Famotidine—Hepatitis—Doxorubicin—stomach cancer	0.000713	0.00109	CcSEcCtD
Famotidine—Insomnia—Capecitabine—stomach cancer	0.000711	0.00109	CcSEcCtD
Famotidine—Rash—Fluorouracil—stomach cancer	0.000709	0.00108	CcSEcCtD
Famotidine—Dermatitis—Fluorouracil—stomach cancer	0.000709	0.00108	CcSEcCtD
Famotidine—Pharyngitis—Doxorubicin—stomach cancer	0.000708	0.00108	CcSEcCtD
Famotidine—Paraesthesia—Capecitabine—stomach cancer	0.000706	0.00108	CcSEcCtD
Famotidine—Decreased appetite—Docetaxel—stomach cancer	0.000706	0.00108	CcSEcCtD
Famotidine—Headache—Fluorouracil—stomach cancer	0.000705	0.00108	CcSEcCtD
Famotidine—Dysgeusia—Methotrexate—stomach cancer	0.000702	0.00107	CcSEcCtD
Famotidine—Fatigue—Docetaxel—stomach cancer	0.0007	0.00107	CcSEcCtD
Famotidine—Nausea—Irinotecan—stomach cancer	0.000698	0.00107	CcSEcCtD
Famotidine—Pain—Docetaxel—stomach cancer	0.000694	0.00106	CcSEcCtD
Famotidine—Constipation—Docetaxel—stomach cancer	0.000694	0.00106	CcSEcCtD
Famotidine—Back pain—Methotrexate—stomach cancer	0.000694	0.00106	CcSEcCtD
Famotidine—Dyspepsia—Capecitabine—stomach cancer	0.000692	0.00106	CcSEcCtD
Famotidine—Arrhythmia—Epirubicin—stomach cancer	0.000689	0.00105	CcSEcCtD
Famotidine—Decreased appetite—Capecitabine—stomach cancer	0.000683	0.00104	CcSEcCtD
Famotidine—Alopecia—Epirubicin—stomach cancer	0.000681	0.00104	CcSEcCtD
Famotidine—Fatigue—Capecitabine—stomach cancer	0.000678	0.00104	CcSEcCtD
Famotidine—Mental disorder—Epirubicin—stomach cancer	0.000675	0.00103	CcSEcCtD
Famotidine—Erythema multiforme—Doxorubicin—stomach cancer	0.000674	0.00103	CcSEcCtD
Famotidine—Constipation—Capecitabine—stomach cancer	0.000672	0.00103	CcSEcCtD
Famotidine—Pain—Capecitabine—stomach cancer	0.000672	0.00103	CcSEcCtD
Famotidine—Feeling abnormal—Docetaxel—stomach cancer	0.000669	0.00102	CcSEcCtD
Famotidine—Nausea—Fluorouracil—stomach cancer	0.000668	0.00102	CcSEcCtD
Famotidine—Tinnitus—Doxorubicin—stomach cancer	0.000665	0.00102	CcSEcCtD
Famotidine—Gastrointestinal pain—Docetaxel—stomach cancer	0.000664	0.00101	CcSEcCtD
Famotidine—Anaemia—Methotrexate—stomach cancer	0.000663	0.00101	CcSEcCtD
Famotidine—Flushing—Doxorubicin—stomach cancer	0.000662	0.00101	CcSEcCtD
Famotidine—Dysgeusia—Epirubicin—stomach cancer	0.000657	0.001	CcSEcCtD
Famotidine—Back pain—Epirubicin—stomach cancer	0.000649	0.000992	CcSEcCtD
Famotidine—Feeling abnormal—Capecitabine—stomach cancer	0.000648	0.00099	CcSEcCtD
Famotidine—Muscle spasms—Epirubicin—stomach cancer	0.000645	0.000986	CcSEcCtD
Famotidine—Gastrointestinal pain—Capecitabine—stomach cancer	0.000643	0.000982	CcSEcCtD
Famotidine—Abdominal pain—Docetaxel—stomach cancer	0.000642	0.000981	CcSEcCtD
Famotidine—Body temperature increased—Docetaxel—stomach cancer	0.000642	0.000981	CcSEcCtD
Famotidine—Leukopenia—Methotrexate—stomach cancer	0.000642	0.000981	CcSEcCtD
Famotidine—Arrhythmia—Doxorubicin—stomach cancer	0.000637	0.000974	CcSEcCtD
Famotidine—Alopecia—Doxorubicin—stomach cancer	0.00063	0.000963	CcSEcCtD
Famotidine—Cough—Methotrexate—stomach cancer	0.000626	0.000956	CcSEcCtD
Famotidine—Mental disorder—Doxorubicin—stomach cancer	0.000625	0.000955	CcSEcCtD
Famotidine—Urticaria—Capecitabine—stomach cancer	0.000624	0.000954	CcSEcCtD
Famotidine—Abdominal pain—Capecitabine—stomach cancer	0.000621	0.00095	CcSEcCtD
Famotidine—Body temperature increased—Capecitabine—stomach cancer	0.000621	0.00095	CcSEcCtD
Famotidine—Convulsion—Methotrexate—stomach cancer	0.000621	0.000949	CcSEcCtD
Famotidine—Anaemia—Epirubicin—stomach cancer	0.00062	0.000948	CcSEcCtD
Famotidine—Agitation—Epirubicin—stomach cancer	0.000617	0.000942	CcSEcCtD
Famotidine—Chest pain—Methotrexate—stomach cancer	0.00061	0.000933	CcSEcCtD
Famotidine—Arthralgia—Methotrexate—stomach cancer	0.00061	0.000933	CcSEcCtD
Famotidine—Myalgia—Methotrexate—stomach cancer	0.00061	0.000933	CcSEcCtD
Famotidine—Dysgeusia—Doxorubicin—stomach cancer	0.000608	0.000929	CcSEcCtD
Famotidine—Syncope—Epirubicin—stomach cancer	0.000602	0.00092	CcSEcCtD
Famotidine—Leukopenia—Epirubicin—stomach cancer	0.000601	0.000918	CcSEcCtD
Famotidine—Back pain—Doxorubicin—stomach cancer	0.000601	0.000918	CcSEcCtD
Famotidine—Hypersensitivity—Docetaxel—stomach cancer	0.000598	0.000914	CcSEcCtD
Famotidine—Muscle spasms—Doxorubicin—stomach cancer	0.000597	0.000912	CcSEcCtD
Famotidine—Palpitations—Epirubicin—stomach cancer	0.000593	0.000906	CcSEcCtD
Famotidine—Confusional state—Methotrexate—stomach cancer	0.00059	0.000902	CcSEcCtD
Famotidine—Loss of consciousness—Epirubicin—stomach cancer	0.00059	0.000901	CcSEcCtD
Famotidine—Cough—Epirubicin—stomach cancer	0.000586	0.000895	CcSEcCtD
Famotidine—Anaphylactic shock—Methotrexate—stomach cancer	0.000585	0.000894	CcSEcCtD
Famotidine—Asthenia—Docetaxel—stomach cancer	0.000583	0.00089	CcSEcCtD
Famotidine—Convulsion—Epirubicin—stomach cancer	0.000581	0.000888	CcSEcCtD
Famotidine—Infection—Methotrexate—stomach cancer	0.000581	0.000888	CcSEcCtD
Famotidine—Hypersensitivity—Capecitabine—stomach cancer	0.000579	0.000885	CcSEcCtD
Famotidine—Pruritus—Docetaxel—stomach cancer	0.000574	0.000878	CcSEcCtD
Famotidine—Anaemia—Doxorubicin—stomach cancer	0.000574	0.000877	CcSEcCtD
Famotidine—Thrombocytopenia—Methotrexate—stomach cancer	0.000573	0.000876	CcSEcCtD
Famotidine—Chest pain—Epirubicin—stomach cancer	0.000571	0.000873	CcSEcCtD
Famotidine—Myalgia—Epirubicin—stomach cancer	0.000571	0.000873	CcSEcCtD
Famotidine—Arthralgia—Epirubicin—stomach cancer	0.000571	0.000873	CcSEcCtD
Famotidine—Agitation—Doxorubicin—stomach cancer	0.000571	0.000872	CcSEcCtD
Famotidine—Anxiety—Epirubicin—stomach cancer	0.000569	0.00087	CcSEcCtD
Famotidine—Asthenia—Capecitabine—stomach cancer	0.000564	0.000862	CcSEcCtD
Famotidine—Dry mouth—Epirubicin—stomach cancer	0.000559	0.000854	CcSEcCtD
Famotidine—Anorexia—Methotrexate—stomach cancer	0.000558	0.000852	CcSEcCtD
Famotidine—Syncope—Doxorubicin—stomach cancer	0.000557	0.000851	CcSEcCtD
Famotidine—Pruritus—Capecitabine—stomach cancer	0.000556	0.00085	CcSEcCtD
Famotidine—Leukopenia—Doxorubicin—stomach cancer	0.000556	0.000849	CcSEcCtD
Famotidine—Diarrhoea—Docetaxel—stomach cancer	0.000555	0.000849	CcSEcCtD
Famotidine—Confusional state—Epirubicin—stomach cancer	0.000552	0.000844	CcSEcCtD
Famotidine—Palpitations—Doxorubicin—stomach cancer	0.000549	0.000838	CcSEcCtD
Famotidine—Oedema—Epirubicin—stomach cancer	0.000548	0.000837	CcSEcCtD
Famotidine—Anaphylactic shock—Epirubicin—stomach cancer	0.000548	0.000837	CcSEcCtD
Famotidine—Loss of consciousness—Doxorubicin—stomach cancer	0.000546	0.000834	CcSEcCtD
Famotidine—Infection—Epirubicin—stomach cancer	0.000544	0.000831	CcSEcCtD
Famotidine—Cough—Doxorubicin—stomach cancer	0.000542	0.000828	CcSEcCtD
Famotidine—Shock—Epirubicin—stomach cancer	0.000539	0.000823	CcSEcCtD
Famotidine—Convulsion—Doxorubicin—stomach cancer	0.000538	0.000822	CcSEcCtD
Famotidine—Diarrhoea—Capecitabine—stomach cancer	0.000538	0.000822	CcSEcCtD
Famotidine—Dizziness—Docetaxel—stomach cancer	0.000537	0.00082	CcSEcCtD
Famotidine—Thrombocytopenia—Epirubicin—stomach cancer	0.000536	0.000819	CcSEcCtD
Famotidine—Musculoskeletal discomfort—Methotrexate—stomach cancer	0.000533	0.000815	CcSEcCtD
Famotidine—Insomnia—Methotrexate—stomach cancer	0.000529	0.000809	CcSEcCtD
Famotidine—Myalgia—Doxorubicin—stomach cancer	0.000529	0.000808	CcSEcCtD
Famotidine—Chest pain—Doxorubicin—stomach cancer	0.000529	0.000808	CcSEcCtD
Famotidine—Arthralgia—Doxorubicin—stomach cancer	0.000529	0.000808	CcSEcCtD
Famotidine—Anxiety—Doxorubicin—stomach cancer	0.000527	0.000805	CcSEcCtD
Famotidine—Paraesthesia—Methotrexate—stomach cancer	0.000525	0.000803	CcSEcCtD
Famotidine—Anorexia—Epirubicin—stomach cancer	0.000522	0.000798	CcSEcCtD
Famotidine—Somnolence—Methotrexate—stomach cancer	0.00052	0.000795	CcSEcCtD
Famotidine—Dizziness—Capecitabine—stomach cancer	0.00052	0.000794	CcSEcCtD
Famotidine—Dry mouth—Doxorubicin—stomach cancer	0.000517	0.00079	CcSEcCtD
Famotidine—Vomiting—Docetaxel—stomach cancer	0.000516	0.000789	CcSEcCtD
Famotidine—Dyspepsia—Methotrexate—stomach cancer	0.000515	0.000787	CcSEcCtD
Famotidine—Rash—Docetaxel—stomach cancer	0.000512	0.000782	CcSEcCtD
Famotidine—Dermatitis—Docetaxel—stomach cancer	0.000511	0.000782	CcSEcCtD
Famotidine—Confusional state—Doxorubicin—stomach cancer	0.000511	0.000781	CcSEcCtD
Famotidine—Decreased appetite—Methotrexate—stomach cancer	0.000509	0.000777	CcSEcCtD
Famotidine—Headache—Docetaxel—stomach cancer	0.000509	0.000777	CcSEcCtD
Famotidine—Oedema—Doxorubicin—stomach cancer	0.000507	0.000774	CcSEcCtD
Famotidine—Anaphylactic shock—Doxorubicin—stomach cancer	0.000507	0.000774	CcSEcCtD
Famotidine—Fatigue—Methotrexate—stomach cancer	0.000504	0.000771	CcSEcCtD
Famotidine—Infection—Doxorubicin—stomach cancer	0.000503	0.000769	CcSEcCtD
Famotidine—Pain—Methotrexate—stomach cancer	0.0005	0.000765	CcSEcCtD
Famotidine—Vomiting—Capecitabine—stomach cancer	0.0005	0.000764	CcSEcCtD
Famotidine—Musculoskeletal discomfort—Epirubicin—stomach cancer	0.000499	0.000762	CcSEcCtD
Famotidine—Shock—Doxorubicin—stomach cancer	0.000499	0.000762	CcSEcCtD
Famotidine—Thrombocytopenia—Doxorubicin—stomach cancer	0.000496	0.000758	CcSEcCtD
Famotidine—Rash—Capecitabine—stomach cancer	0.000496	0.000757	CcSEcCtD
Famotidine—Insomnia—Epirubicin—stomach cancer	0.000495	0.000757	CcSEcCtD
Famotidine—Dermatitis—Capecitabine—stomach cancer	0.000495	0.000757	CcSEcCtD
Famotidine—Headache—Capecitabine—stomach cancer	0.000492	0.000753	CcSEcCtD
Famotidine—Paraesthesia—Epirubicin—stomach cancer	0.000492	0.000751	CcSEcCtD
Famotidine—Somnolence—Epirubicin—stomach cancer	0.000487	0.000744	CcSEcCtD
Famotidine—Anorexia—Doxorubicin—stomach cancer	0.000483	0.000738	CcSEcCtD
Famotidine—Nausea—Docetaxel—stomach cancer	0.000482	0.000737	CcSEcCtD
Famotidine—Feeling abnormal—Methotrexate—stomach cancer	0.000482	0.000737	CcSEcCtD
Famotidine—Dyspepsia—Epirubicin—stomach cancer	0.000482	0.000737	CcSEcCtD
Famotidine—Gastrointestinal pain—Methotrexate—stomach cancer	0.000478	0.000731	CcSEcCtD
Famotidine—Decreased appetite—Epirubicin—stomach cancer	0.000476	0.000727	CcSEcCtD
Famotidine—Fatigue—Epirubicin—stomach cancer	0.000472	0.000721	CcSEcCtD
Famotidine—Constipation—Epirubicin—stomach cancer	0.000468	0.000716	CcSEcCtD
Famotidine—Pain—Epirubicin—stomach cancer	0.000468	0.000716	CcSEcCtD
Famotidine—Nausea—Capecitabine—stomach cancer	0.000467	0.000713	CcSEcCtD
Famotidine—Urticaria—Methotrexate—stomach cancer	0.000465	0.00071	CcSEcCtD
Famotidine—Abdominal pain—Methotrexate—stomach cancer	0.000463	0.000707	CcSEcCtD
Famotidine—Body temperature increased—Methotrexate—stomach cancer	0.000463	0.000707	CcSEcCtD
Famotidine—Musculoskeletal discomfort—Doxorubicin—stomach cancer	0.000462	0.000705	CcSEcCtD
Famotidine—Insomnia—Doxorubicin—stomach cancer	0.000458	0.0007	CcSEcCtD
Famotidine—Paraesthesia—Doxorubicin—stomach cancer	0.000455	0.000695	CcSEcCtD
Famotidine—Feeling abnormal—Epirubicin—stomach cancer	0.000451	0.00069	CcSEcCtD
Famotidine—Somnolence—Doxorubicin—stomach cancer	0.00045	0.000688	CcSEcCtD
Famotidine—Gastrointestinal pain—Epirubicin—stomach cancer	0.000448	0.000684	CcSEcCtD
Famotidine—Dyspepsia—Doxorubicin—stomach cancer	0.000446	0.000682	CcSEcCtD
Famotidine—Decreased appetite—Doxorubicin—stomach cancer	0.00044	0.000673	CcSEcCtD
Famotidine—Fatigue—Doxorubicin—stomach cancer	0.000437	0.000668	CcSEcCtD
Famotidine—Urticaria—Epirubicin—stomach cancer	0.000435	0.000665	CcSEcCtD
Famotidine—Constipation—Doxorubicin—stomach cancer	0.000433	0.000662	CcSEcCtD
Famotidine—Pain—Doxorubicin—stomach cancer	0.000433	0.000662	CcSEcCtD
Famotidine—Abdominal pain—Epirubicin—stomach cancer	0.000433	0.000662	CcSEcCtD
Famotidine—Body temperature increased—Epirubicin—stomach cancer	0.000433	0.000662	CcSEcCtD
Famotidine—Hypersensitivity—Methotrexate—stomach cancer	0.000431	0.000659	CcSEcCtD
Famotidine—Asthenia—Methotrexate—stomach cancer	0.00042	0.000642	CcSEcCtD
Famotidine—Feeling abnormal—Doxorubicin—stomach cancer	0.000418	0.000638	CcSEcCtD
Famotidine—Gastrointestinal pain—Doxorubicin—stomach cancer	0.000414	0.000633	CcSEcCtD
Famotidine—Pruritus—Methotrexate—stomach cancer	0.000414	0.000633	CcSEcCtD
Famotidine—Hypersensitivity—Epirubicin—stomach cancer	0.000403	0.000617	CcSEcCtD
Famotidine—Urticaria—Doxorubicin—stomach cancer	0.000403	0.000615	CcSEcCtD
Famotidine—Abdominal pain—Doxorubicin—stomach cancer	0.000401	0.000612	CcSEcCtD
Famotidine—Body temperature increased—Doxorubicin—stomach cancer	0.000401	0.000612	CcSEcCtD
Famotidine—Diarrhoea—Methotrexate—stomach cancer	0.0004	0.000612	CcSEcCtD
Famotidine—Asthenia—Epirubicin—stomach cancer	0.000393	0.0006	CcSEcCtD
Famotidine—Pruritus—Epirubicin—stomach cancer	0.000387	0.000592	CcSEcCtD
Famotidine—Dizziness—Methotrexate—stomach cancer	0.000387	0.000591	CcSEcCtD
Famotidine—Diarrhoea—Epirubicin—stomach cancer	0.000375	0.000573	CcSEcCtD
Famotidine—Hypersensitivity—Doxorubicin—stomach cancer	0.000373	0.00057	CcSEcCtD
Famotidine—Vomiting—Methotrexate—stomach cancer	0.000372	0.000569	CcSEcCtD
Famotidine—Rash—Methotrexate—stomach cancer	0.000369	0.000564	CcSEcCtD
Famotidine—Dermatitis—Methotrexate—stomach cancer	0.000369	0.000563	CcSEcCtD
Famotidine—Headache—Methotrexate—stomach cancer	0.000367	0.00056	CcSEcCtD
Famotidine—Asthenia—Doxorubicin—stomach cancer	0.000364	0.000556	CcSEcCtD
Famotidine—Dizziness—Epirubicin—stomach cancer	0.000362	0.000553	CcSEcCtD
Famotidine—Pruritus—Doxorubicin—stomach cancer	0.000358	0.000548	CcSEcCtD
Famotidine—Vomiting—Epirubicin—stomach cancer	0.000348	0.000532	CcSEcCtD
Famotidine—Nausea—Methotrexate—stomach cancer	0.000348	0.000531	CcSEcCtD
Famotidine—Diarrhoea—Doxorubicin—stomach cancer	0.000347	0.00053	CcSEcCtD
Famotidine—Rash—Epirubicin—stomach cancer	0.000345	0.000528	CcSEcCtD
Famotidine—Dermatitis—Epirubicin—stomach cancer	0.000345	0.000527	CcSEcCtD
Famotidine—Headache—Epirubicin—stomach cancer	0.000343	0.000524	CcSEcCtD
Famotidine—HRH2—Signaling by GPCR—KISS1R—stomach cancer	0.000338	0.0036	CbGpPWpGaD
Famotidine—HRH2—Class A/1 (Rhodopsin-like receptors)—ANXA1—stomach cancer	0.000337	0.0036	CbGpPWpGaD
Famotidine—Dizziness—Doxorubicin—stomach cancer	0.000335	0.000512	CcSEcCtD
Famotidine—HRH2—Class A/1 (Rhodopsin-like receptors)—ADRB1—stomach cancer	0.000327	0.00349	CbGpPWpGaD
Famotidine—Nausea—Epirubicin—stomach cancer	0.000325	0.000497	CcSEcCtD
Famotidine—Vomiting—Doxorubicin—stomach cancer	0.000322	0.000492	CcSEcCtD
Famotidine—Rash—Doxorubicin—stomach cancer	0.000319	0.000488	CcSEcCtD
Famotidine—Dermatitis—Doxorubicin—stomach cancer	0.000319	0.000488	CcSEcCtD
Famotidine—Headache—Doxorubicin—stomach cancer	0.000317	0.000485	CcSEcCtD
Famotidine—HRH2—GPCRs, Class A Rhodopsin-like—ADRB2—stomach cancer	0.000309	0.0033	CbGpPWpGaD
Famotidine—SLC47A1—SLC-mediated transmembrane transport—ALB—stomach cancer	0.000301	0.00321	CbGpPWpGaD
Famotidine—Nausea—Doxorubicin—stomach cancer	0.000301	0.00046	CcSEcCtD
Famotidine—HRH2—GPCR ligand binding—AGTR2—stomach cancer	0.000276	0.00295	CbGpPWpGaD
Famotidine—HRH2—GPCR ligand binding—F2R—stomach cancer	0.000273	0.00292	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—HRH4—stomach cancer	0.000269	0.00287	CbGpPWpGaD
Famotidine—SLC22A2—Transmission across Chemical Synapses—HSPA8—stomach cancer	0.000269	0.00287	CbGpPWpGaD
Famotidine—SLC22A8—Transmembrane transport of small molecules—SLC1A2—stomach cancer	0.000266	0.00284	CbGpPWpGaD
Famotidine—HRH2—GPCR ligand binding—HTR1A—stomach cancer	0.000266	0.00284	CbGpPWpGaD
Famotidine—HRH2—Class A/1 (Rhodopsin-like receptors)—ADRB2—stomach cancer	0.000265	0.00282	CbGpPWpGaD
Famotidine—HRH2—GPCR ligand binding—ANXA1—stomach cancer	0.000257	0.00274	CbGpPWpGaD
Famotidine—SLC47A1—Transmembrane transport of small molecules—HMOX1—stomach cancer	0.000255	0.00272	CbGpPWpGaD
Famotidine—HRH2—GPCR ligand binding—ADRB1—stomach cancer	0.000249	0.00265	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—HRH4—stomach cancer	0.000244	0.00261	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—KISS1—stomach cancer	0.00024	0.00256	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—KISS1—stomach cancer	0.000218	0.00232	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—GAST—stomach cancer	0.000206	0.0022	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—RGS2—stomach cancer	0.000206	0.0022	CbGpPWpGaD
Famotidine—SLC22A2—Neuronal System—HSPA8—stomach cancer	0.000206	0.0022	CbGpPWpGaD
Famotidine—HRH2—GPCR ligand binding—ADRB2—stomach cancer	0.000202	0.00215	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—GLI3—stomach cancer	0.000199	0.00213	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—KISS1R—stomach cancer	0.000199	0.00213	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—ACAD8—stomach cancer	0.000199	0.00213	CbGpPWpGaD
Famotidine—SLC47A1—Transmembrane transport of small molecules—APOA1—stomach cancer	0.000193	0.00206	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—RBP1—stomach cancer	0.00019	0.00203	CbGpPWpGaD
Famotidine—CYP2C19—Biological oxidations—GSTT1—stomach cancer	0.000187	0.002	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—RGS2—stomach cancer	0.000187	0.002	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—GAST—stomach cancer	0.000187	0.002	CbGpPWpGaD
Famotidine—SLC22A2—Transmembrane transport of small molecules—SLC1A2—stomach cancer	0.000185	0.00198	CbGpPWpGaD
Famotidine—CYP2C19—Biological oxidations—CYP2A6—stomach cancer	0.000185	0.00198	CbGpPWpGaD
Famotidine—CYP2C19—Arachidonic acid metabolism—PTGS2—stomach cancer	0.000181	0.00193	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—GMPR2—stomach cancer	0.000178	0.0019	CbGpPWpGaD
Famotidine—CYP2C19—Metapathway biotransformation—AKR1C3—stomach cancer	0.000178	0.0019	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—SUCLG1—stomach cancer	0.000163	0.00174	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—IDH3B—stomach cancer	0.000163	0.00174	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—PPAP2A—stomach cancer	0.000162	0.00172	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—AGTR2—stomach cancer	0.000156	0.00167	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—WWOX—stomach cancer	0.000155	0.00166	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—F2R—stomach cancer	0.000154	0.00165	CbGpPWpGaD
Famotidine—SLC47A1—Transmembrane transport of small molecules—ALB—stomach cancer	0.000153	0.00163	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—NDUFV1—stomach cancer	0.000151	0.00161	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—NDUFS1—stomach cancer	0.000151	0.00161	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—HTR1A—stomach cancer	0.00015	0.0016	CbGpPWpGaD
Famotidine—SLC22A2—Transmission across Chemical Synapses—PRKCB—stomach cancer	0.000147	0.00156	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—ANXA1—stomach cancer	0.000145	0.00155	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—HRH4—stomach cancer	0.000144	0.00154	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—WIF1—stomach cancer	0.000144	0.00154	CbGpPWpGaD
Famotidine—SLC22A8—SLC-mediated transmembrane transport—ALB—stomach cancer	0.000142	0.00151	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—AGTR2—stomach cancer	0.000142	0.00151	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—ADRB1—stomach cancer	0.000141	0.0015	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—F2R—stomach cancer	0.00014	0.0015	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—HTR1A—stomach cancer	0.000136	0.00146	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—PLIN2—stomach cancer	0.000135	0.00144	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—PGLS—stomach cancer	0.000135	0.00144	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—BLVRB—stomach cancer	0.000135	0.00144	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—PRKAB1—stomach cancer	0.000133	0.00142	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—ANXA1—stomach cancer	0.000132	0.00141	CbGpPWpGaD
Famotidine—CYP2C19—Biological oxidations—GSTP1—stomach cancer	0.00013	0.00139	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—KISS1—stomach cancer	0.000129	0.00137	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—RNF43—stomach cancer	0.000129	0.00137	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—PPAP2A—stomach cancer	0.000129	0.00137	CbGpPWpGaD
Famotidine—CYP2C19—Metapathway biotransformation—GSTP1—stomach cancer	0.000128	0.00137	CbGpPWpGaD
Famotidine—HRH2—Class A/1 (Rhodopsin-like receptors)—CXCL8—stomach cancer	0.000128	0.00136	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—ADRB1—stomach cancer	0.000128	0.00136	CbGpPWpGaD
Famotidine—SLC22A8—Transmembrane transport of small molecules—HMOX1—stomach cancer	0.00012	0.00128	CbGpPWpGaD
Famotidine—CYP2C19—Biological oxidations—GSTM1—stomach cancer	0.000119	0.00127	CbGpPWpGaD
Famotidine—CYP2C19—Metapathway biotransformation—GSTM1—stomach cancer	0.000118	0.00126	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—FST—stomach cancer	0.000115	0.00122	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—CA1—stomach cancer	0.000115	0.00122	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—FBP1—stomach cancer	0.000115	0.00122	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—NDUFA2—stomach cancer	0.000115	0.00122	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—CKB—stomach cancer	0.000115	0.00122	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—ADRB2—stomach cancer	0.000114	0.00122	CbGpPWpGaD
Famotidine—SLC22A2—Neuronal System—PRKCB—stomach cancer	0.000112	0.0012	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—HBEGF—stomach cancer	0.000112	0.0012	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—ACAD8—stomach cancer	0.000112	0.00119	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—GAST—stomach cancer	0.000111	0.00118	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—RGS2—stomach cancer	0.000111	0.00118	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—ECHS1—stomach cancer	0.000109	0.00116	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—PLIN2—stomach cancer	0.000108	0.00115	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—FGG—stomach cancer	0.000105	0.00112	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—CA2—stomach cancer	0.000105	0.00112	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—ADRB2—stomach cancer	0.000103	0.0011	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—FADS1—stomach cancer	0.000103	0.00109	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—NT5E—stomach cancer	0.000102	0.00109	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—PGAM1—stomach cancer	0.000102	0.00109	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—PPP2R1A—stomach cancer	0.000101	0.00108	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—PRKAA1—stomach cancer	0.000101	0.00108	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—GMPR2—stomach cancer	9.95e-05	0.00106	CbGpPWpGaD
Famotidine—SLC22A2—SLC-mediated transmembrane transport—ALB—stomach cancer	9.87e-05	0.00105	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—RBP4—stomach cancer	9.74e-05	0.00104	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—PLCE1—stomach cancer	9.74e-05	0.00104	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—ALDH7A1—stomach cancer	9.74e-05	0.00104	CbGpPWpGaD
Famotidine—HRH2—GPCR ligand binding—CXCL8—stomach cancer	9.73e-05	0.00104	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—SREBF2—stomach cancer	9.6e-05	0.00103	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—RORA—stomach cancer	9.49e-05	0.00101	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—UMPS—stomach cancer	9.34e-05	0.000997	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—IDH3B—stomach cancer	9.1e-05	0.000971	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—SUCLG1—stomach cancer	9.1e-05	0.000971	CbGpPWpGaD
Famotidine—SLC22A8—Transmembrane transport of small molecules—APOA1—stomach cancer	9.1e-05	0.000971	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—ECHS1—stomach cancer	8.68e-05	0.000927	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—PDHA1—stomach cancer	8.68e-05	0.000927	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—NDUFS1—stomach cancer	8.46e-05	0.000903	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—NDUFV1—stomach cancer	8.46e-05	0.000903	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—HSPB1—stomach cancer	8.37e-05	0.000894	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—AGTR2—stomach cancer	8.37e-05	0.000894	CbGpPWpGaD
Famotidine—SLC22A2—Transmembrane transport of small molecules—HMOX1—stomach cancer	8.35e-05	0.000892	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—BMP2—stomach cancer	8.28e-05	0.000884	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—F2R—stomach cancer	8.28e-05	0.000884	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—ALOX5—stomach cancer	8.27e-05	0.000883	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—TYMP—stomach cancer	8.16e-05	0.000871	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—FADS1—stomach cancer	8.16e-05	0.000871	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—AKR1C3—stomach cancer	8.15e-05	0.00087	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—HTR1A—stomach cancer	8.06e-05	0.00086	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—PRKCB—stomach cancer	7.81e-05	0.000833	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—ANXA1—stomach cancer	7.79e-05	0.000831	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—SREBF2—stomach cancer	7.64e-05	0.000816	CbGpPWpGaD
Famotidine—SLC22A2—Transmission across Chemical Synapses—MAPK1—stomach cancer	7.55e-05	0.000806	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—RORA—stomach cancer	7.55e-05	0.000806	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—ADRB1—stomach cancer	7.54e-05	0.000805	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—BLVRB—stomach cancer	7.54e-05	0.000805	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—PGLS—stomach cancer	7.54e-05	0.000805	CbGpPWpGaD
Famotidine—SLC22A8—Transmembrane transport of small molecules—ALB—stomach cancer	7.21e-05	0.000769	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—RPS6—stomach cancer	7.2e-05	0.000769	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—PPAP2A—stomach cancer	7.19e-05	0.000768	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—PRKCB—stomach cancer	7.09e-05	0.000757	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—ALDOB—stomach cancer	7.08e-05	0.000755	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—IL6ST—stomach cancer	7.06e-05	0.000754	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C3—stomach cancer	6.92e-05	0.000738	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—HBEGF—stomach cancer	6.62e-05	0.000707	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—ALOX5—stomach cancer	6.58e-05	0.000702	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—DPYD—stomach cancer	6.47e-05	0.000691	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—CKB—stomach cancer	6.41e-05	0.000684	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—FBP1—stomach cancer	6.41e-05	0.000684	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—CA1—stomach cancer	6.41e-05	0.000684	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—NDUFA2—stomach cancer	6.41e-05	0.000684	CbGpPWpGaD
Famotidine—SLC22A2—Transmembrane transport of small molecules—APOA1—stomach cancer	6.33e-05	0.000676	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—IL6R—stomach cancer	6.3e-05	0.000672	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—RHOA—stomach cancer	6.27e-05	0.000669	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—ADRB2—stomach cancer	6.11e-05	0.000652	CbGpPWpGaD
Famotidine—SLC22A2—Transmission across Chemical Synapses—HRAS—stomach cancer	6.06e-05	0.000647	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—PLIN2—stomach cancer	6.03e-05	0.000643	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—PPP2R1A—stomach cancer	5.99e-05	0.000639	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—CA2—stomach cancer	5.86e-05	0.000626	CbGpPWpGaD
Famotidine—SLC22A2—Neuronal System—MAPK1—stomach cancer	5.79e-05	0.000618	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—GSTT1—stomach cancer	5.72e-05	0.000611	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—PGAM1—stomach cancer	5.71e-05	0.00061	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—NT5E—stomach cancer	5.71e-05	0.00061	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—RHOA—stomach cancer	5.69e-05	0.000607	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—CYP2A6—stomach cancer	5.66e-05	0.000604	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—SMAD4—stomach cancer	5.56e-05	0.000593	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—AKR1C3—stomach cancer	5.5e-05	0.000587	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—CXCL8—stomach cancer	5.5e-05	0.000587	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—ALDH7A1—stomach cancer	5.45e-05	0.000582	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—PLCE1—stomach cancer	5.45e-05	0.000582	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—ENO1—stomach cancer	5.36e-05	0.000572	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—FYN—stomach cancer	5.28e-05	0.000563	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—UMPS—stomach cancer	5.23e-05	0.000558	CbGpPWpGaD
Famotidine—SLC22A2—Transmembrane transport of small molecules—ALB—stomach cancer	5.02e-05	0.000535	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—CXCL8—stomach cancer	4.99e-05	0.000533	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—FGFR2—stomach cancer	4.95e-05	0.000529	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—PDHA1—stomach cancer	4.86e-05	0.000519	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—ECHS1—stomach cancer	4.86e-05	0.000519	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—CD44—stomach cancer	4.76e-05	0.000508	CbGpPWpGaD
Famotidine—SLC22A2—Neuronal System—HRAS—stomach cancer	4.65e-05	0.000496	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—TYMP—stomach cancer	4.57e-05	0.000488	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—FADS1—stomach cancer	4.57e-05	0.000488	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—IRS2—stomach cancer	4.54e-05	0.000484	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—CAV1—stomach cancer	4.4e-05	0.00047	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—APOA1—stomach cancer	4.39e-05	0.000469	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—SREBF2—stomach cancer	4.28e-05	0.000457	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—RORA—stomach cancer	4.23e-05	0.000451	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—PRKCB—stomach cancer	4.19e-05	0.000447	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—IL6ST—stomach cancer	4.17e-05	0.000445	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—PPP2R1A—stomach cancer	4.04e-05	0.000432	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—APC—stomach cancer	4.01e-05	0.000428	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—GSTP1—stomach cancer	3.97e-05	0.000423	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—ALDOB—stomach cancer	3.96e-05	0.000423	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—HMOX1—stomach cancer	3.91e-05	0.000418	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—MAPK3—stomach cancer	3.84e-05	0.00041	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	3.73e-05	0.000399	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	3.73e-05	0.000398	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—IL6R—stomach cancer	3.72e-05	0.000397	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—TYMS—stomach cancer	3.69e-05	0.000394	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—ALOX5—stomach cancer	3.68e-05	0.000393	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—MAPK1—stomach cancer	3.65e-05	0.00039	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—EGFR—stomach cancer	3.65e-05	0.00039	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—GSTM1—stomach cancer	3.65e-05	0.000389	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—DPYD—stomach cancer	3.62e-05	0.000387	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—PIK3CA—stomach cancer	3.49e-05	0.000372	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—SERPINE1—stomach cancer	3.48e-05	0.000372	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—KRAS—stomach cancer	3.45e-05	0.000368	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—ERCC2—stomach cancer	3.43e-05	0.000366	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—RHOA—stomach cancer	3.36e-05	0.000359	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—NOS3—stomach cancer	3.33e-05	0.000355	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	3.28e-05	0.00035	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—MTHFR—stomach cancer	3.22e-05	0.000344	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—GSTT1—stomach cancer	3.2e-05	0.000342	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—PIK3CA—stomach cancer	3.17e-05	0.000338	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—CYP2A6—stomach cancer	3.17e-05	0.000338	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—ERBB2—stomach cancer	3.11e-05	0.000332	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—AKR1C3—stomach cancer	3.08e-05	0.000329	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—ENO1—stomach cancer	3e-05	0.00032	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—CAV1—stomach cancer	2.97e-05	0.000317	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—APOA1—stomach cancer	2.96e-05	0.000316	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—stomach cancer	2.95e-05	0.000315	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—CXCL8—stomach cancer	2.95e-05	0.000315	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—HRAS—stomach cancer	2.93e-05	0.000313	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—CDKN1B—stomach cancer	2.88e-05	0.000308	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—IL6—stomach cancer	2.81e-05	0.000299	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—CCND1—stomach cancer	2.75e-05	0.000293	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—JUN—stomach cancer	2.74e-05	0.000293	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—MMP9—stomach cancer	2.67e-05	0.000285	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—CD44—stomach cancer	2.66e-05	0.000284	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—CDKN1A—stomach cancer	2.66e-05	0.000284	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—PPARG—stomach cancer	2.61e-05	0.000279	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—MAPK8—stomach cancer	2.6e-05	0.000277	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	2.58e-05	0.000276	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—VEGFA—stomach cancer	2.4e-05	0.000256	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—STAT3—stomach cancer	2.37e-05	0.000253	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—ALB—stomach cancer	2.35e-05	0.000251	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—MAPK3—stomach cancer	2.27e-05	0.000242	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—PPP2R1A—stomach cancer	2.26e-05	0.000242	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—NOS3—stomach cancer	2.25e-05	0.00024	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—GSTP1—stomach cancer	2.22e-05	0.000237	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—MYC—stomach cancer	2.2e-05	0.000235	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—HMOX1—stomach cancer	2.19e-05	0.000234	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—MAPK1—stomach cancer	2.16e-05	0.00023	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—EGFR—stomach cancer	2.16e-05	0.00023	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—TYMS—stomach cancer	2.06e-05	0.00022	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—PTGS2—stomach cancer	2.06e-05	0.000219	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—GSTM1—stomach cancer	2.04e-05	0.000218	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—KRAS—stomach cancer	2.04e-05	0.000217	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—ERCC2—stomach cancer	1.92e-05	0.000205	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—PIK3CA—stomach cancer	1.87e-05	0.0002	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—TP53—stomach cancer	1.81e-05	0.000193	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—MTHFR—stomach cancer	1.8e-05	0.000192	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—HRAS—stomach cancer	1.73e-05	0.000185	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—CAV1—stomach cancer	1.66e-05	0.000178	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—APOA1—stomach cancer	1.66e-05	0.000177	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—IL6—stomach cancer	1.66e-05	0.000177	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	1.59e-05	0.00017	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—PPARG—stomach cancer	1.46e-05	0.000156	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—ALB—stomach cancer	1.31e-05	0.00014	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—PIK3CA—stomach cancer	1.26e-05	0.000135	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—NOS3—stomach cancer	1.26e-05	0.000134	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—PTGS2—stomach cancer	1.15e-05	0.000123	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—PIK3CA—stomach cancer	7.08e-06	7.55e-05	CbGpPWpGaD
